(R)-2-Methyl-pyrrolidine hydrochloride, 97.0%, 1g

2-Methyl-1-(piperazin-1-yl)propan-2-ol, 98%, 1g

6-Maleimidohexanoic Acid>98.0%(GC)(T)5g

2-(2-(2-Methoxyethoxy)ethoxy)ethanol, 95.00%, 500g

(6-bromo-1H-indol-1-yl)acetic acid, 95%, 100mg

2-Hydroxy-5-iodo-benzaldehyde, 98.0%, 1g

Flacons à vis autonomes stériles, 1,5 ml, 500 pièce(s)

({[4-(trifluoromethoxy)phenyl]methyl}sulfanyl)methanimidamide hydrobromide, 95.0%, 5g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indole-1-carboxylate, 95.0%, 5g

N-Ethyl-3-hydroxybenzamide, 10g

3-FLUORO-2-METHOXYPHENACYL BROMIDE, 95.0%, 250mg

1-(2-bromoethyl)-2-methyl-1H-imidazole hydrobromide, 95.0%, 1g

2-(2-BROMOPHENYL)ACETOHYDRAZIDE, 95.0%, 5g